Hedtmann A, Krämer J, Steffen R
Neurochirurgia (Stuttg). 1986 Sep;29 Suppl 1:161-6. doi: 10.1055/s-2008-1054103.
In a comparative study 71 patients were treated by intradiscal injection of collagenase and 93 patients by chymopapain injections. Indication, technique of injection and post-injection treatment were based on uniform criteria and followed standardised procedure. In practically all cases, monosegmental injections were performed almost exclusively in the last two discs of the lumbar vertebral column; in cases where the x-ray and clinical findings were unequivocal, the injections were performed at one level of the lumbar vertebral column. After collagenase injection, patients suffered more from low back pain, needed higher doses of strong analgesics, and had a longer hospital stay. Results after one year were almost equal with success rates of 75% (chymopapain) and 72% (collagenase). In each group about three-quarters of the patients with unsatisfactory results were operated on.
在一项对比研究中,71例患者接受了椎间盘内注射胶原酶治疗,93例患者接受了木瓜凝乳蛋白酶注射治疗。注射指征、注射技术及注射后治疗均基于统一标准并遵循标准化程序。在几乎所有病例中,单节段注射几乎仅在腰椎柱的最后两个椎间盘进行;在X线和临床检查结果明确的病例中,注射在腰椎柱的一个节段进行。注射胶原酶后,患者腰痛更严重,需要更高剂量的强效镇痛药,住院时间更长。一年后的结果几乎相同,木瓜凝乳蛋白酶组成功率为75%,胶原酶组为72%。每组中约四分之三效果不理想的患者接受了手术治疗。